-
Mashup Score: 1
People with rheumatic and musculoskeletal diseases who experience breakthrough SARS-CoV-2 infection after vaccination have lower rates of poor COVID-19 outcomes than their unvaccinated counterparts, researchers report.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0EULAR | Volunteering with EULAR PARE - 2 year(s) ago
By volunteering for EULAR PARE, you will be joining a family of people dedicated to making a difference to improve the lives of people with RMDs. Our volunteers tell us that they benefit from being involved with EULAR PARE by: receiving professional support to develop skills, working as part of a team, meeting like-minded, committed people, and learning more about their own disease and…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0EULAR 2022 – Registration - 2 year(s) ago
Delegates with prescription authorisation are members of the medical, dental or pharmacy professions who, in the course of his or her professional activities may prescribe, recommend, purchase, supply, sell or administer a pharmaceutical product. EULAR will request a confirmation. Proof of status is required Delegates without prescription authorisation are medical or scientific…
Source: congress.eular.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5EULAR | World arthritis day - 3 year(s) ago
World Arthritis Day, referred to as WAD, is a global awareness day held every year on 12 October. WAD aims to help raise awareness in all audiences across the world of the existence and impact of rheumatic and musculoskeletal diseases, often referred to as RMDs. The debilitating effects of these diseases, of which more than 200 exist, are little known; their impact, however, is largely – and…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 6
Background We describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an online, international survey of adults with systemic rheumatic disease who received COVID-19 vaccination. We collected patient-reported data on clinician communication, beliefs and intent about discontinuing…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases - 3 year(s) ago
Patients with rheumatic diseases are at increased risk of infectious complications; vaccinations are a critical component of their care. Disease-modifying antirheumatic drugs may reduce the immunogenicity of common vaccines. We will review here available data regarding the effect of these medications on influenza, pneumococcal, herpes zoster, SARS-CoV-2, hepatitis B, human papilloma virus and…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Background The registration trials of messenger RNA (mRNA) vaccines against SARS-CoV-2 did not address patients with inflammatory rheumatic diseases (IRD). Objective To assess the humoral response after two doses of mRNA vaccine against SARS-CoV-2, in patients with IRD treated with immunomodulating drugs and the impact on IRD activity. Methods Consecutive patients treated at the rheumatology…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Initial data from the COVAX Registry offer reassurance for patients with rheumatic and musculoskeletal diseases that adverse events with the COVID-19 vaccines are similar to those seen in the general population.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 3
Pedro Machado presents COVID-19 vaccine safety data supporting their use for patients with rheumatic and musculoskeletal diseases.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1ReWe-21 - 3 year(s) ago
Welcome to the EULAR Research webinar series The webinar series is focused on providing theoretical and hands-on advice on conducting research to improve the lives of people with RMDs. It will highlight how-to advice, latest EULAR research support offerings (e.g., resources, services, tools, databases, funding opportunities), and tips from…
Source: esor.eular.orgCategories: Latest Headlines, RheumatologyTweet
News in brief: Study findings from Petros Sfikakis (@uoaofficial) @FragoulisGeorge @AKaramanakos & team emphasize “critical importance” of full #COVID19 vaccination in people with rheumatic diseases #RMDs @ARD_BMJ https://t.co/27OfoABxQN